Cargando…
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
Currently used factors predicting disease recurrence in stage II colorectal cancer patients are not optimal for risk stratification. Thus, new biomarkers are needed. In this study the applicability of ezrin protein expression together with MSI status and BRAF mutation status were tested in predictin...
Autores principales: | Slik, Khadija, Kurki, Samu, Korpela, Taina, Carpén, Olli, Korkeila, Eija, Sundström, Jari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617236/ https://www.ncbi.nlm.nih.gov/pubmed/28953975 http://dx.doi.org/10.1371/journal.pone.0185436 |
Ejemplares similares
-
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2018) -
Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017) -
Real-world features associated with cancer-related venous thromboembolic events
por: Peippo, Maija Helena, et al.
Publicado: (2018) -
Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004) -
Protein phosphatase methylesterase‐1 (PME‐1) expression predicts a favorable clinical outcome in colorectal cancer
por: Kaur, Amanpreet, et al.
Publicado: (2015)